PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial

PURPOSE: Endometrioid endometrial cancer is strongly associated with obesity and insulin resistance. Metformin,an insulin sensitizer, reduces endometrial tumor growth in vitro. Presurgical window studies allow rapid in vivo assessment of antitumor activity. Previous window studies found metformin re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Kitson, Sarah J., Maskell, Zoe, Sivalingam, Vanitha N., Allen, Jennifer L., Ali, Saad, Burns, Sean, Gilmour, Kyle, Latheef, Rahamatulla, Slade, Richard J., Pemberton, Philip W., Shaw, Joseph, Ryder, W. David, Kitchener, Henry C., Crosbie, Emma J.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586555/
https://ncbi.nlm.nih.gov/pubmed/30563932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3339
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker